Boehringer Sues Mylan To Block Generic Aggrenox
Boehringer Ingelheim Pharmaceuticals Inc. slammed Mylan Pharmaceuticals Inc. with a lawsuit in West Virginia federal court on Friday, alleging the company's plan to market a generic version of Aggrenox, a long-acting...To view the full article, register now.
Already a subscriber? Click here to view full article